Registry of Sleep Apnea Monitoring and Atrial Fibrillation in Pacemaker Patients (RESPIRE)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of the study is to evaluate at 12 Months follow-up the association between Atrial Fibrillation (AF) and Sleep Apnea (SA) severity based on data measured and stored in REPLY 200 DR pacemaker.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patient eligible for implantation of a dual-chamber pacemaker (primo-implant, replacement, upgrade) according to current available guidelines Patient with REPLY 200 DR implantation performed. Patient who provides signed and dated informed consent according to the local laws and regulations
Patient eligible for implantation of a dual-chamber pacemaker according to current available guidelines
Patient with REPLY 200 DR implantation performed
Patient who provides signed and dated informed consent (according to the laws and regulations of the country in which the observational study is conducted)
Inability to understand the purpose of the study or refusal to co-operate
Unavailability for routine follow-ups at the implanting centre
Already included in another clinical study that could affect the results of this study
Inability or refusal to provide informed consent
Patient is minor (less than 18-years old)
Patient is pregnant
Patient is forfeiture of freedom or under guardianship